GlaxoSmithKline (GSK) will take a $2.36 billion charge to settle most Avandia product liability cases and other litigation facing the company.rnThe settlements include suits regarding the diabetes drug Avandia (rosiglitazone) and liability and antitrust litigation over its drug Paxil (paroxetine), GSK said Thursday.
展开▼